JPWO2019199874A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019199874A5 JPWO2019199874A5 JP2020555504A JP2020555504A JPWO2019199874A5 JP WO2019199874 A5 JPWO2019199874 A5 JP WO2019199874A5 JP 2020555504 A JP2020555504 A JP 2020555504A JP 2020555504 A JP2020555504 A JP 2020555504A JP WO2019199874 A5 JPWO2019199874 A5 JP WO2019199874A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- substituted
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862655723P | 2018-04-10 | 2018-04-10 | |
| US62/655,723 | 2018-04-10 | ||
| PCT/US2019/026646 WO2019199874A1 (fr) | 2018-04-10 | 2019-04-09 | Dérivés de morpholine en tant qu'inhibiteurs de vps34 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521179A JP2021521179A (ja) | 2021-08-26 |
| JPWO2019199874A5 true JPWO2019199874A5 (fr) | 2022-04-13 |
| JP7369140B2 JP7369140B2 (ja) | 2023-10-25 |
Family
ID=66248835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555504A Active JP7369140B2 (ja) | 2018-04-10 | 2019-04-09 | Ｖｐｓ３４の阻害剤としてのモルホリン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11236079B2 (fr) |
| EP (1) | EP3774792B1 (fr) |
| JP (1) | JP7369140B2 (fr) |
| KR (1) | KR20200142549A (fr) |
| CN (1) | CN112533917B (fr) |
| AU (1) | AU2019251363B2 (fr) |
| CA (1) | CA3095512A1 (fr) |
| EA (1) | EA202092446A1 (fr) |
| ES (1) | ES2929292T3 (fr) |
| MX (1) | MX2020010577A (fr) |
| SG (1) | SG11202008851UA (fr) |
| WO (1) | WO2019199874A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112189012B (zh) | 2018-04-10 | 2024-02-13 | 神经孔疗法股份有限公司 | 作为pi3激酶和自噬途径的调节剂的三取代芳基和杂芳基衍生物 |
| SG11202008851UA (en) | 2018-04-10 | 2020-10-29 | Neuropore Therapies Inc | Morpholine derivates as inhibitors of vps34 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2660B1 (en) * | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| MY180595A (en) | 2006-12-07 | 2020-12-03 | Genentech Inc | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| WO2009066084A1 (fr) | 2007-11-21 | 2009-05-28 | F. Hoffmann-La Roche Ag | 2-morpholinopyrimidines et leur utilisation en tant qu'inhibiteurs de kinase pi3 |
| MX339584B (es) * | 2009-09-09 | 2016-06-01 | Avila Therapeutics Inc | Inhibidores de pi3 cinasa y usos de los mismos. |
| CA2831582C (fr) * | 2011-03-28 | 2019-01-08 | Mei Pharma, Inc. | (aralkylamino et heteroarylalkylamino alpha-substitues)pyrimidinyl- et 1,3,5-triazinylbenzimidazoles, compositions pharmaceutiques associees etleur utilisation dans le traitement de maladies proliferatives |
| DK3416957T3 (da) * | 2016-02-19 | 2020-09-21 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes |
| US10774064B2 (en) | 2016-06-02 | 2020-09-15 | Cadent Therapeutics, Inc. | Potassium channel modulators |
| SG11202008851UA (en) | 2018-04-10 | 2020-10-29 | Neuropore Therapies Inc | Morpholine derivates as inhibitors of vps34 |
-
2019
- 2019-04-09 SG SG11202008851UA patent/SG11202008851UA/en unknown
- 2019-04-09 JP JP2020555504A patent/JP7369140B2/ja active Active
- 2019-04-09 EA EA202092446A patent/EA202092446A1/ru unknown
- 2019-04-09 CN CN201980032053.2A patent/CN112533917B/zh active Active
- 2019-04-09 WO PCT/US2019/026646 patent/WO2019199874A1/fr active Application Filing
- 2019-04-09 KR KR1020207032483A patent/KR20200142549A/ko not_active Application Discontinuation
- 2019-04-09 CA CA3095512A patent/CA3095512A1/fr active Pending
- 2019-04-09 ES ES19719103T patent/ES2929292T3/es active Active
- 2019-04-09 EP EP19719103.4A patent/EP3774792B1/fr active Active
- 2019-04-09 AU AU2019251363A patent/AU2019251363B2/en active Active
- 2019-04-09 US US17/046,750 patent/US11236079B2/en active Active
- 2019-04-09 MX MX2020010577A patent/MX2020010577A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6227707B2 (ja) | Ｍｃｌ‐１を調節する小分子、並びに細胞死、細胞分裂、細胞分化を調節する方法、及び疾患を治療する方法。 | |
| TWI323659B (en) | Novel thiazolidin-4-one derivatives | |
| EP2917190B1 (fr) | Nouveaux composés de benzène sulfonamide thiazole | |
| EP1986633B1 (fr) | Traitement de la dystrophie musculaire de duchenne | |
| CA2626402A1 (fr) | Inhibiteurs du canal potassique | |
| NZ627750A (en) | Carbamate compounds and of making and using same | |
| CA2694270A1 (fr) | Aryloxazoles substitues et leur utilisation | |
| JP2006501295A5 (fr) | ||
| HUP0402264A2 (hu) | Szubsztituált 2-tio-3,5-diciano-4-fenil-6-aminopiridinek, előállításuk, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| JP2018504393A5 (fr) | ||
| JP2006517572A5 (fr) | ||
| JP2010510237A5 (fr) | ||
| JP2023002701A5 (fr) | ||
| JP2020534264A5 (fr) | ||
| JP2004532894A5 (fr) | ||
| KR920701178A (ko) | 3-아릴옥사졸리디논 유도체, 그의 제조방법 및 그의 치료 용도 | |
| JPWO2019199874A5 (fr) | ||
| JP2020516616A5 (fr) | ||
| JP2019533007A5 (fr) | ||
| RU2008103452A (ru) | Фторзамещенные производные 2-оксо-азепана | |
| JPS5944370A (ja) | 融合環４ｈ−１，４−ベンゾチアジン、その製法及び医薬としての使用 | |
| JPWO2007004733A1 (ja) | ペルオキシソーム増殖剤活性化受容体δの活性化剤 | |
| MXPA02001740A (es) | Uso de bis-sulfonamidas para producir medicinas para la profilaxis o tratamiento de hiperlipidemia. | |
| JP2020509043A5 (fr) | ||
| JPWO2021129653A5 (fr) |